Navigation Links
Blue Belt Technologies, Inc. Closes Series A Financing
Date:9/30/2009

nd enhanced accuracy while performing bone shaping tasks through minimally invasive incisions. The Precision Freehand Sculpting (PFS) system utilizes a compact, handheld, intelligent tool to assist the surgeon in accurately cutting bone. Its control system monitors the position of the tool and adjusts the depth of cut (or disables cutting entirely) based on its proximity to bone that it should -- or should not -- remove.

Blue Belt Technologies, Inc. initially plans to release a computer assisted bone shaping product for spine, hip and knee based procedures via its "PFS Developers Kit" to allow existing surgical navigation platforms to integrate PFS capability seamlessly onto the estimated 8,000 navigation systems installed worldwide in a very cost effective manner. The Company is also developing an independent platform for other bone based procedures.

The Company is also a finalist for the Pittsburgh Technology Council's Tech 50 Awards recognizing Blue Belt Technologies, Inc. as one of southwestern Pennsylvania's most successful and innovative technology companies. The Company has also launched an updated website (www.bluebelttech.com), and has finalized its surgeon advisory board to include world renowned surgeons in both orthopaedics and neurosurgery.

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises. The PLSG supports biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG is propelling the sustainable growth of the region's life sciences economy by accelerating research and technology commercialization with seed and early-stage companies; connecting in
'/>"/>

SOURCE Blue Belt Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor
2. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
3. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
4. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
5. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
6. Wound Management Technologies, Inc. Announces Evidence Based Study
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  BD (Becton, Dickinson and ... technology company, announced today that it will present at the ... Thursday, May 30, 2013, at 10:40 a.m. (ET). ... from the BD corporate website at www.bd.com/investors and ... About BD BD is a ...
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... England and BOSTON , May 24, ... discovery and development company, is pleased to announce that it has ... to augment the Company,s business development capabilities in Japan ... more than 15 years of experience in business development, licensing and ... Sciences, Inc., Roche Pharma ( Japan ), Nippon Roche ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Scientist to Present Results at 2007 American ... 09, 2007 /PRNewswire-FirstCall/ -- Cleveland,BioLabs, Inc. , ... of,Protectan CBLB502's efficacy as a mitigator of ... damage in non-human primates. The,Company's Chief Scientific ...
... Pa.--(BUSINESS WIRE)--Apr 9, 2007 -,GlaxoSmithKline (LSE and ... from Study 767905/014 and,provided an update on ... 014, a Phase 3, double blind, placebo-controlled ... long-term safety and,tolerability of alvimopan 0.5 mg ...
Cached Medicine Technology:Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 2Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 2GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 3GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 4GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 5GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 6GSK and Adolor Announce Preliminary Results from Phase 3 Safety,Study of Alvimopan (Entereg/Entrareg) 7
(Date:5/25/2013)... Many viruses and parasites that affect both dogs and ... illness than can result in liver or kidney failure ... a veterinarian. These germs could be found ... Dr. Susan Nelson, a clinical associate professor at Kansas ... diseases can be fatal, even with treatment," she said ...
(Date:5/25/2013)... May 25, 2013 The report ... By Types, Functions, Applications, Ingredients, Shell Materials, Packaging, ... the global food encapsulation market with analysis and ... It also identifies the driving and restraining factors ... of trends, opportunities, and challenges. The market is ...
(Date:5/25/2013)... May 25, 2013 Studies from Johns ... are carrying excessive weight and their inability to get ... simply losing weight can naturally relieve many symptoms. ... improvement in sleep quality was significantly associated with overall ... study dated November 6th, 2012, researchers monitored ...
(Date:5/25/2013)... Center, FL (PRWEB) May 25, 2013 Absolute ... one of many of the NALA’s businesses throughout the country ... Amshel chose to participate in the nationwide event as he ... a Lieutenant Colonel in the Army. He said, “I wanted ... the community I serve, but I live here too.” , ...
(Date:5/25/2013)... 2013 Pradaxa lawsuits filed ... of internal bleeding while using the blood thinner continue to ... Southern District of Illinois, Bernstein Liebhard LLP reports. According ... effect claims had been filed in the litigation ... claims reported by the Court on May 15th. ( In ...
Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3
... initiation of lifesaving antiretroviral therapies should be the standard of ... limited medical and financial resources, according to a study led ... Tutu HIV Centre, University of Cape Town, South Africa. ... Internal Medicine that starting antiretroviral therapy (ART) when the ...
... , LOS ANGELES, July 20 Dr. Chugay, a leading ... patch procedure to aid patients with goals of rapid weight loss. , ... over thir ty years of experience and has personally performed ... surgery expert on The Tonight Show , Entertainment Weekly , CNN ...
... , FLEMINGTON, N.J., July 20 A new national ... (82%) do not believe that drugs containing acetaminophen should be pulled ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO ) , , ... during July 17-19, to obtain physicians, perceptions of a CNN news ...
... , , NEW YORK, ... controversial and thought provoking topics today, MTV,s "16 & Pregnant" season ... (2.1 million) on Thursday, July 16, ranking as the number one ... their favorite series with the "16 & Pregnant: Life After Labor" ...
... working on H1N1 swine flu vaccine, which should be ready ... U.S. Food and Drug Administration has approved the vaccine to ... , The agency noted that this vaccine will not protect ... pandemic proportions around the world and is expected to return ...
... , GREENFIELD, Wis., July 20 ... nutritional service and meal-planning program for cancer patients. The web-based ... . Founded by cancer survivors, the program is based ... It is available to cancer patients and health care systems ...
Cached Medicine News:Health News:Earlier HIV antiviral treatment can be cost effective in areas of limited resources 2Health News:Dr. Chugay (drchugay.com) - Revolutionary Weight Loss Surgery 2Health News:Docs Say No to Pulling Drugs Containing Acetaminophen off the Market 2Health News:Docs Say No to Pulling Drugs Containing Acetaminophen off the Market 3Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 2Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 3Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 4Health News:MTV's Season Finale of '16 & Pregnant' Hit Series Highs Among Both P12-34 (1.9) and Total Viewers (2.1 Million) Thursday, Ranking as the Number One Primetime Cable Program 5Health News:FDA Approves Seasonal Flu Vaccine for 2009-2010 2Health News:FDA Approves Seasonal Flu Vaccine for 2009-2010 3Health News:Cancer Survivors Launch New Company, TherapEase Cuisine 2
Anterior chamber protein cell meter. Laser flare meter and cell-counting functions are included in this cell meter, with dramatically enhanced measurement of cell volume....
... new SureSigns VS1 is an ... monitor that provides reliable, accurate, ... VS1 is designed to make ... like large, bright, color-coded LED ...
... High-performance monitoring at the patients side and ... monitors provide essential measurements in a compact ... needs of post-operative care, lower acuity environments, ... strong heritage in patient monitoring, the IntelliVue ...
... Built on Philips strong heritage in ... configuration; an extensive clinical measurements menu; built-in ... EASI* derived 12-lead ECG, and arrhythmia analysis; ... is easy to use and operates on ...
Medicine Products: